Liebe Besucherinnen und Besucher,
aufgrund unseres Sommerfestes sind wir am 03. September 2026 bis 14 Uhr erreichbar. Am 04. September 2026 sind wir wieder wie gewohnt für Sie da. Vielen Dank für Ihr Verständnis.
Ihr Team von Sack Fachmedien
E-Book, Englisch, 250 Seiten
Reihe: EcoProduction
Khoobchandani / Saxena Biotechnology Products in Everyday Life
1. Auflage 2018
ISBN: 978-3-319-92399-4
Verlag: Springer International Publishing
Format: PDF
Kopierschutz: 1 - PDF Watermark
E-Book, Englisch, 250 Seiten
Reihe: EcoProduction
ISBN: 978-3-319-92399-4
Verlag: Springer International Publishing
Format: PDF
Kopierschutz: 1 - PDF Watermark
This book explores a sampling of the most powerful and enterprising efforts to achieve biotechnological goals by means of various interdisciplinary approaches. From the fabrication of extremely small units to achieve specific objectives through nano-bio-technology, to devices with artificial intelligence, gene therapy for cerebrovascular anomalies, biodegradable plastics, the use of phyto-stem cells in cosmetology, CarT cell immune therapy, targeted therapies for cancer, 3D printed bones developed by the University of Wollongong in Australia, the sickle cell chip developed by IIT Bombay, and innovative sustainable energy solutions, the book includes a colorful spectrum of reviews on current and future biotech products. Gathering contributions by an international team of researchers, this book offers its audience, and particularly younger readers, revealing information on current and upcoming smart technologies.
Dr. Menka Khoobchandani is currently a Research Scientist at the University of Missouri, Columbia, USA, after finishing her PhD from DayalbaghEducational Institute, India. With ten years of research and academic experience, her focus areas are cancer biology, drug discovery, and material sciences. Dr. Arpita Saxena is a social entrepreneur, striving to better the social education system in India with her AAPT concept. Arpita holds a PhD in Biotechnology and has seven years of experience in anticancer therapeutics in affiliation with the CSIR and BIRAC.




